Patient Safety · April 20, 2026 · 10 min read

One Pill a Day, If You Can Afford It: Inside America's Prescription Crisis

42% of Americans changed how they take prescriptions due to cost in 2025. From insulin rationing to prior authorization denials, the US prescription system is quietly breaking patients who are doing everything right.

TL;DR

America's prescription system is not just expensive — it actively causes patients to make medically dangerous decisions every day just to financially survive.

42% of Americans made changes to how they take prescriptions due to cost in 2025 — up from 34% in 2024, and accelerating
125,000 Americans die each year from not taking prescribed medications as directed — medication non-adherence costs the system $300 billion annually
1.3 million Americans with diabetes ration insulin; those who do are 3x more likely to have poor glycemic control
Prior authorization requirements caused serious adverse events in over 25% of physician surveys — and 8% of physicians report it has led directly to patient death or permanent disability
18 million Americans cannot afford their needed prescriptions at all — they go without

Denise is 58 years old, works part-time at a garden center in Tulsa, and has had Type 1 diabetes since she was nineteen. She knows exactly what happens to her body when she doesn't take enough insulin. She has been in diabetic ketoacidosis twice. She knows what the hospital bill looks like after a DKA episode. She also knows what her insulin costs at the pharmacy — $340 for a month's supply — and what her paycheck looks like on the first of the month when rent is due.

So she does what 1.3 million Americans with diabetes do: she rations. She takes 80% of the recommended dose and eats less to compensate. Some mornings she skips the dose entirely and monitors her blood sugar every hour on a glucometer that she bought on eBay because the new continuous glucose monitors require a prescription her insurance keeps denying. "I know it's dangerous," she told a diabetes support group online. "I'm not an idiot. I'm just broke."

Denise is not in the margins of the American healthcare story. She is the middle of it. In 2025, for the first time, a majority of lower-income Americans — those earning under $40,000 a year — reported rationing their prescriptions due to cost. One in five people who filled any prescription that year reported making changes to how they took their medication: splitting pills, skipping doses, or not filling the prescription at all. The number has climbed every single year since 2020.

What makes this particularly brutal is that none of these patients are abandoning treatment out of negligence or ignorance. They have been prescribed medicines by doctors who determined those medicines were necessary. They are choosing between medically necessary treatment and financial survival. The prescription system — between its drug pricing, its insurance bureaucracies, and its fragmented management infrastructure — is making that choice necessary for tens of millions of people who thought having a prescription meant they could get the medicine.

The Math That Doesn't Work

The simplest way to understand the American prescription crisis is to look at what changed between 2024 and 2025. In 2024, 34% of Americans reported making at least one change to how they managed their prescriptions due to cost. By 2025, that number was 42%. In one year, nearly 8% more of the country shifted from "I can afford my medications" to "I have to make trade-offs."

42%

of Americans made prescription changes due to cost in 2025 — up from 34% in 2024

18M

Americans cannot pay for their needed prescriptions at all

1 in 5

of all prescription fillers reported rationing — skipping doses, splitting pills, or not filling

52%

of adults earning under $40,000/year report non-filling, splitting, or skipping doses

The specific behaviors are worth naming clearly because "cost burden" as a phrase is abstract. What 42% of Americans actually did in 2025: asked their doctor for a cheaper alternative, used a coupon service like GoodRx or a patient assistance program, split a higher-dose pill to double supply, skipped doses to stretch a month's supply further, did not fill the prescription at all, or switched to an over-the-counter substitute that was less effective. Nearly 30% reported cutting back on food or clothing to pay for prescriptions.

46%

of Americans in 2025 reported taking actions that negatively impacted their lifestyle or personal finances just to manage prescription costs — up from 37% in 2024 (GoodRx Research, 2025)

The insurance coverage you have matters less than you might think. Among people with private insurance — the coverage many Americans pay thousands of dollars per year to maintain — 18.8% still report rationing insulin. Among uninsured Americans, the figure is 29.2%. But the gap is smaller than the insurance industry's marketing would suggest. Having insurance is not the same as being able to afford your prescriptions. High-deductible plans, prior authorizations, formulary restrictions, and specialty drug tiers mean that millions of insured Americans face the same impossible math as the uninsured — just with a slightly higher floor before the fall.

I have insurance through my employer. I pay $480 a month in premiums. My rheumatologist prescribed a biologic for my RA and the copay after insurance is $890 a month. I am not sure what the word "insurance" is supposed to mean at this point.
— Patient comment, KFF Health Costs Tracking Poll, 2025

The compounding risk: When patients ration medications for chronic conditions — hypertension, diabetes, heart failure, rheumatoid arthritis — they do not feel the consequences immediately. The damage accumulates silently: blood sugar drifts up over three months of undertreated diabetes; blood pressure creeps higher over six months of half-doses. When the crisis arrives, it arrives fast. An ER visit costs $3,000. A hospitalization costs $15,000. The "savings" from skipping doses is paid back with devastating interest.

The Prior Authorization Nightmare

Even for patients who can afford their prescriptions, the American system has invented a second obstacle: prior authorization. Before your insurance will pay for a medicine your doctor has prescribed, you may need to obtain approval from the insurance company — a process that involves your doctor's office submitting clinical paperwork, waiting for a determination, and sometimes appealing a denial before the process can even begin.

In theory, prior authorization exists to ensure that expensive treatments are medically necessary. In practice, it functions as a delay and denial mechanism that transfers clinical decision-making from physicians to insurance company reviewers — often non-physicians — who assess patients they have never seen using criteria that are not publicly available.

What prior authorization looks like on the ground: A physician prescribes a medication. The pharmacist tells the patient it requires prior authorization. The patient waits. The doctor's office submits the PA form — one of approximately 40 prior authorizations the average physician completes per week. The insurance company has up to 72 hours to respond for non-urgent requests. If denied, the doctor can appeal. If the appeal is denied, the doctor can request a peer-to-peer review — a phone call with an insurance reviewer. During all of this, the patient has no medication. This process, for a single prescription, can take 2–4 weeks.

prior authorizations per week the average physician completes — taken away from patient care time

25%+

of physicians report prior auth has led to serious adverse events for their patients

of physicians report prior auth has led to patient death or permanent disability

92%

of oncologists report experiencing prior authorization delays for cancer patients

A 2025 Johns Hopkins review of 25 US studies found that prior authorization requirements are directly associated with delays in care, disease exacerbations, preventable hospitalizations, prolonged inpatient stays, and lower rates of disease-free survival in cancer care. The findings span oncology, cardiology, behavioral health, pediatrics, rheumatology, and infectious diseases — essentially every major specialty.

My patient had a pulmonary embolism. I prescribed a blood thinner. Prior authorization required. Three days later, still waiting. I had to prescribe a less effective alternative just to get something in her. The insurance eventually approved the original medication after two weeks. She had already been discharged. The window where it mattered most — she spent it without the right drug.
— Internist, quoted in AMA Prior Authorization Survey, 2025

In June 2025, major US health insurers — Aetna, UnitedHealthcare, Cigna, Humana, Elevance Health, and Blue Cross Blue Shield — announced agreements to streamline prior authorization processes. The reforms are described by critics as frustratingly vague on specifics. Physicians note that the commitment to "streamline" does not address the fundamental problem: that treatment decisions are being made by insurance reviewers, not the treating physician, based on financial rather than clinical criteria.

Specialty	% experiencing prior auth delays	Documented harm
Oncology	92% of oncologists	7% of oncologists report patient deaths attributable to PA delays
Cardiology	Majority	Restricted anticoagulant access leaving AFib patients at higher stroke risk
Behavioral health	Widespread	Treatment interruptions, higher relapse rates, worse outcomes in psychiatric illness
Rheumatology	High	Disease flares, joint damage during treatment gaps for biologics
Pediatrics	Significant	Delays in developmental and psychiatric medication access

Key Takeaway

Prior authorization is a system that transfers clinical authority from physicians to insurance reviewers — creating treatment gaps during which patients deteriorate, worsen, or die. The evidence of harm is documented across every major medical specialty.

What 125,000 Deaths Look Like

The number that receives surprisingly little public attention: 125,000 Americans die each year because they do not take their prescribed medications as directed. This is not from overdose. It is from under-treatment — from the accumulated consequences of half-doses, missed doses, discontinued courses, and prescriptions never filled.

Medication non-adherence is estimated to contribute to approximately 25% of all hospitalizations in the United States. The economic cost — healthcare expenditures that would not have occurred if patients had been able to take their medications as prescribed — is estimated at $100 to $300 billion per year. The human cost has no adequate measure.

125,000

Americans die annually due to medication non-adherence — making it one of the most preventable causes of death in the country, larger than car accidents or firearm deaths

The mechanics of how non-adherence kills are mundane and slow. A patient with hypertension takes half their prescribed dose for six months because the full supply costs $180 a month and they can stretch it to $90 by halving doses. Their blood pressure, which the full dose would have controlled at 120/80, stays at 145/95. One morning, eighteen months later, they have a stroke. The connection between the pill-splitting in 2024 and the stroke in 2026 will not appear in any data about prescription affordability. It will appear in stroke statistics.

The chronic disease spiral: Non-adherence in chronic conditions creates a vicious cycle. Skipped doses lead to worsening control of the underlying condition. Worsening control leads to new complications. New complications require additional medications or treatments. The additional treatments cost more. The patient who was rationing one medication is now managing three, at even higher cost. The medical debt created by the original decision to skip doses often exceeds what the original medication would have cost over years of consistent use.

I see patients in the emergency department who stopped taking their blood pressure medication because they couldn't afford it. They come in with a hypertensive crisis. The ER visit alone costs more than two years of the medication they stopped taking. We treat the crisis, stabilize them, and send them home — back to the same conditions that brought them here. The math is insane.
— Emergency Physician, quoted in AJMC, 2025

Elderly Americans are disproportionately affected. Among adults over 65, approximately 44% of men and 57% of women take five or more prescription and non-prescription medications per week. Twelve percent of people in this age group take ten or more. Managing this many medicines without a system — without reminders, without a complete consolidated list, without low-stock alerts — produces adherence failures that are predictable, preventable, and ultimately fatal at scale.

Non-adherence behavior	Prevalence	Documented consequence
Not filling a new prescription	20–30% of new prescriptions	Untreated condition progresses from day one of non-filling
Not refilling a long-term prescription	50% of chronic disease patients within the first year	Loss of disease control, elevated risk of hospitalization
Taking less than prescribed dose	Widespread, especially with cost as driver	Sub-therapeutic levels — medicine present but insufficient for clinical effect
Stopping without medical advice	Common in psychiatric medications, antibiotics	Relapse, resistance, or dangerous discontinuation effects
Taking at wrong times or skipping days	Up to 50–60% of chronic disease patients	Erratic blood levels, especially dangerous for anticoagulants, diabetes drugs

Rationing Insulin in the World's Richest Country

Insulin is not a lifestyle drug. It is not optional. For people with Type 1 diabetes and many with Type 2, skipping insulin is not a cost-saving measure — it is a path to diabetic ketoacidosis, a medical emergency that can result in coma or death within hours. Every clinician who treats diabetes knows this. Every patient with insulin-dependent diabetes knows this. And yet 1.3 million Americans are doing it anyway — because the alternative is not affording rent.

1.3M

Americans are estimated to be rationing insulin due to cost — skipping doses, taking less than prescribed, or delaying purchase (Lown Institute, estimated from national survey data)

The forms of insulin rationing are grimly inventive. Patients split doses and eat less to compensate for the lower insulin. They use expired insulin because it is cheaper or because a relative saved a partially-used vial. They switch between rapid-acting and long-acting formulations in ways that are not clinically appropriate. They use older, cheaper insulin formulations that require more precise meal timing and carry higher risk of hypoglycemia. Some go to Walmart and buy over-the-counter regular insulin — $25 a vial — which requires a completely different dosing approach from what their doctor prescribed.

I started rationing my insulin two years ago when I lost my job and my insurance. I didn't tell my endocrinologist because I was ashamed. By the time I came in for my next appointment, my A1C was 11.2. She asked what happened. I showed her my bank account. She cried. I cried. Then she found me a patient assistance program, which I should have been told about years ago. I was almost blind in one eye by that point from uncontrolled sugar.
— Diabetes patient, online forum, 2025 (anonymised)

The clinical consequences are precisely what you would expect from medically unsupervised under-dosing of a critical hormone. Patients who ration insulin are three times more likely to have poor glycemic control than those who do not. Poor glycemic control, sustained over months or years, drives the progression of every diabetes complication: retinopathy leading to blindness, nephropathy leading to dialysis, neuropathy leading to amputations, cardiovascular disease. The deaths from insulin rationing are the outermost point of a continuum that begins with every skipped dose.

State-level insulin caps do not fully solve the problem: Several US states have enacted insulin copay caps of $35 or less per month. Research published in 2025 found that even in states with copay caps, rationing rates remain higher than they should be — because many uninsured patients are not covered by copay caps (which apply to insured individuals), and because high deductible plans mean patients may pay full price until their deductible is met.

Key Takeaway

Insulin rationing is not a behavior problem — it is a pricing and access problem that the healthcare system has failed to solve. The consequences manifest in slower, invisible ways: rising A1C, progressing neuropathy, worsening eyesight — until a crisis forces an expensive hospitalization that costs far more than years of properly dosed insulin would have.

The Elderly American's Impossible Medication Juggle

The prescription crisis is not distributed evenly. For elderly Americans managing multiple chronic conditions — and that is most elderly Americans — the problem compounds. Each specialist adds a prescription. Each condition requires a separate medication. The administrative burden of managing those prescriptions: remembering doses, tracking refills, coordinating prior authorizations, monitoring for interactions, filing insurance claims — falls not on the healthcare system, but on the patient or their family.

Among Americans over 65, 44% of men and 57% of women take five or more prescription and non-prescription medications per week. Twelve percent take ten or more. The clinical term is polypharmacy, and it creates adherence failures that have nothing to do with cost — they have to do with cognitive load, complicated schedules, confusing instructions, and a healthcare system that adds medications without ever subtracting.

57%

of American women over 65 take 5+ medications per week

12%

of all Americans over 65 take 10+ medications per week — hyperpolypharmacy

50%

of patients prescribed chronic medications do not take them as prescribed after the first year

$300B

estimated annual cost of medication non-adherence to the US healthcare system

The American version of the medicine management problem looks different from India's fragmented-specialist model, but arrives at the same place: a patient trying to manage a complex regimen without adequate tools or support. In America, the complications are often insurance-driven: some medicines are covered on some plans, others require prior authorization that must be renewed annually, formularies change, and the patient must navigate a re-authorization bureaucracy to continue a medication they have been stable on for three years. Meanwhile, the pharmacist dispenses each medication in a separate amber bottle with a different refill date, and the patient — or more often, their adult child — tries to track ten separate refill schedules, ten separate copays, and ten separate sets of instructions.

My mother is on eight medications. I set up a spreadsheet to track her refills. She has three different pharmacies because one chain is better for her blood pressure medication, one has a discount program for her diabetes supplies, and the third is where she goes because she trusts the pharmacist. Every month is a puzzle. When she was hospitalized last year, the hospital asked me to list all her medications. I was on the phone for twenty minutes reading from my spreadsheet while they waited. No one had a complete list anywhere.
— Adult caregiver, Chicago, shared in a family caregiving online forum

The real burden of polypharmacy is often on caregivers: Research consistently shows that elderly patients on complex medication regimens depend heavily on a family caregiver — usually an adult child — to manage adherence. That caregiver is typically managing their own life, their own work, and potentially a family, in addition to tracking their parent's ten medications across multiple pharmacies and insurance plans. The cognitive and logistical burden of this role is enormous and largely invisible to the healthcare system.

Adherence barrier	Who is most affected	Common outcome
Cost — cannot afford medication	Uninsured, underinsured, low-income	Non-filling, dose rationing, dangerous alternatives
Prior authorization delays	Patients needing specialty medications	Treatment gap, disease progression, hospitalization
Complex regimen — too many medications	Elderly, multimorbid patients	Missed doses, confusion, interaction risk
Running out between refills	All patients — especially multi-med elderly	Unplanned gaps in chronic disease management
No reminder system	Elderly living alone, cognitively declining patients	Forgotten doses, poor adherence even when willing and able
Multiple pharmacies — no unified view	Elderly with multiple conditions and specialists	No single point of visibility for interactions or refill gaps

What Better Prescription Management Actually Looks Like

A lot of the American prescription crisis is structural — pricing, insurance architecture, prior authorization — and requires policy solutions that individual patients cannot create for themselves. But one specific and addressable part of the problem is information management: the gap between what a patient's prescriptions actually say and what the patient, their caregiver, and their next treating physician actually know.

The person most harmed by information fragmentation is not the uninsured patient without access — they know exactly what they cannot access. It is the patient managing multiple medications across multiple providers and multiple pharmacies who thinks they are on top of things, right up until they are not. Until the refill gap that sends the blood pressure out of control. Until the interaction that the second specialist would have caught, if they had known about the first specialist's prescription. Until the ER admission where nobody has a complete medication list and the admitting physician has to make treatment decisions without one.

125,000

deaths annually from medication non-adherence — many preventable with better adherence support, consolidated records, and timely low-stock alerts

MedLogsRx addresses the information and adherence layer of this problem directly. The prescription scanner handles the part that most patients abandon first: the manual entry of each medication's name, dose, frequency, and refill date. Photograph the prescription label or the pharmacy printout — the AI reads it and pulls the data into a clean medicine list automatically. Every prescription from every provider ends up in one place.

Scan

Photograph any prescription label or printout — AI reads and extracts medicine name, dose, and schedule automatically

One list

All prescriptions from all providers in a single consolidated view — the complete medication record that no American provider system currently maintains for you

Alerts

Dose reminders for every medication, every schedule — and low-stock alerts before any prescription runs out

Show any provider the complete medication list at any visit — no more reconstructing it from memory in an ER at 2am

The low-stock alert is specifically valuable for Americans managing multiple prescriptions with different refill dates, different prior authorization renewal cycles, and different pharmacy locations. Running out of a blood pressure medication on a Friday afternoon — when the doctor's office is closed and the Monday refill requires a new prior authorization — is not a minor inconvenience. It is a treatment gap that, stretched over enough incidents, accumulates into meaningful clinical harm. A notification three days before you run out changes the entire calculus.

For caregivers managing a parent's medications remotely: MedLogsRx's caregiver alerts mean that an adult child in a different city can see, at a glance, whether their parent took their medications today — and can receive a notification if they did not. For elderly Americans living alone on complex regimens, this layer of oversight is the difference between a missed dose being noticed in time and a hospitalization two weeks later.

My dad has Parkinson's and hypertension and takes seven medications. After I started logging everything in MedLogsRx, I pulled up his full list at his next neurology appointment. The neurologist looked at it and said one of his blood pressure medications can worsen Parkinson's symptoms. His cardiologist had prescribed it two years ago and the neurologist had no idea. Two years. Now we have it changed. That list finally being in one place was worth everything.
— Adult caregiver, Dallas, managing father's multi-specialist treatment (MedLogsRx user)

The American prescription system's structural problems — cost, insurance bureaucracy, prior authorization — are real, documented, and deeply resistant to quick fixes. They require policy reform that is measured in legislative cycles, not app updates. But the adherence layer — missed doses, refill gaps, incomplete medication records, caregiver coordination failures — is addressable right now, with better tools.

Denise in Tulsa is still rationing her insulin. That is a policy failure that no app can solve. But the patient next to her in the endocrinologist's waiting room — the one who is taking his medications properly, who just has no system for tracking them, who keeps running out on weekends, who cannot remember if he took the morning dose — that patient is the person MedLogsRx was built for. And in a system that generates 125,000 preventable deaths a year from non-adherence, reaching that person matters.

Download MedLogsRx on the App Store →